The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Bibliography: Domestic Policy Issues
Steps Toward Evidence-Based Regulation of Controlled Cannabinoids in Non-Medicinal CBD Products
Steps Toward Evidence-Based Regulation of Controlled Cannabinoids in Non-Medicinal CBD Products addresses the most pressing questions that precede the formulation of Government policy on cannabidiol (CBD), making the crucial recommendation of a medically considered lower limit for THC content in non-controlled cannabinoid-containing products; the “zero-threshold” (e Conservative Drug Policy Reform Group)
Government of Canada supports four safer drug supply projects in British Columbia
Life-saving initiatives will provide pharmaceutical-grade medication as alternative to toxic illegal drug supply during COVID-19 outbreak and beyond (Government of Canada)
Groundbreaking drug decriminalization law goes into effect today
people will no longer be arrested and jailed for possession of small amounts of drugs, thanks to Oregonians who voted overwhelmingly for ballot Measure 110. Oregon is the first state in the U.S. to decriminalize simple possession of all drugs (Health Justice Recovery Alliance)
Drug offences sentencing guidelines revised as offending changes
A comprehensive package of revised sentencing guidelines for drugs offences that reflect a change in the nature of offending and additional offences in relation to psychoactive substances has been published today by the Sentencing Council following consultation (Sentencing Council, UK)
UK government Drug Recovery Champion annual report
The first annual report from the UK Recovery Champion outlines the work he has undertaken since his appointment and sets out his future work programme (Home Office)
CCSA and Health Canada Invest $1.8 Million in Cannabis Research Projects
The Canadian Centre on Substance Use and Addiction (CCSA) is investing $1.8 million dollars in research on non-therapeutic cannabis and the impacts of its legalization on public health and safety throughout the country
£148 million to cut drugs crime
Multimillion pound investment and ‘Project ADDER’ to protect communities from crime caused by illegal drugs (UK Government)
State of the Nation 2020
A stocktake of how New Zealand is dealing with the issue of drugs (NZDF)
Engel Releases Western Hemisphere Drug Policy Commission Report
The report, which was transmitted to Congress this week and can be found here, provides critical recommendations that will help policymakers improve U.S. drug policy in Latin America and the Caribbean (House of Representatives, USA)
Focused on the Future: Strategic Plan 2021–2026
Provides the action plan for the Canadian Centre on Substance Use and Addiction (CCSA) for the years 2021 through 2026. The strategic plan presents the Centre’s three strategic priorities and two North Star outcomes. It also outlines the methods CCSA will use to achieve these outcomes
Cannabis based products for medicinal use in humans (CBPMs)
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified (AMCD)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Synthetic cannabinoid receptor agonists
This report provides an updated harms assessment to the ACMD’s previous reports on synthetic cannabinoid receptor agonists
Police powers and procedures, England and Wales, year ending 31 March 2020
Statistics on stop and search, arrests for notifiable offences, detentions under the Mental Health Act 1983, fixed penalty notices for motoring offences, breath tests, and other PACE powers (Home Office)
Response to the ACMD report on the misuse of fentanyl and fentanyl analogues
The following is a partial response to your recommendations as further work is required to implement some of these. I have indicated below where this applies (Home Office)
COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both (Public Health England)
Recommendations from the Labour Campaign for Drug Policy Reform (LCDPR)
Compiled by its Expert Working Group
Problem-solving courts pilot announced
On 16 September 2020, the Ministry of Justice (MoJ) published a white paper, A smarter approach to sentencing (Legal Action Group)
The National Survey on Drug Use and Health: 2019 (PDF)
NSDUH is a comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States (SAMHSA)
Cancard: backed by police, designed with doctors, made for patients
From 1 November this year, over 1 million adults will be eligible to apply for a new exemption card, Cancard, which has been designed by medical cannabis patients to protect them from prosecution (CDPRG)
Recreational cannabis regulation and harm reduction
BERL advice to the Ministry of Justice (New Zealand)
Overdose Education and Naloxone Distribution Within Syringe Service Programs — United States, 2019
In 2019, among 263 SSPs responding to an online survey, 247 (94%) had implemented OEND. The number of persons who received naloxone per opioid overdose death and the number of naloxone doses distributed per opioid overdose death during the previous year varied by census division (CDC)
Access to take-home naloxone increased through paramedic supply
Ambulance paramedics are to supply to patients at risk of an opiate overdose take-home naloxone as part of a pilot scheme in Glasgow (SDF)
ACMD work programme 2020 to 2022: commissioning letter
The Home Secretary’s commissioning letter to the chair of the Advisory Council on the Misuse of Drugs (ACMD) for the period 2020 to 2022
Scottish Drug Deaths Taskforce: One Year Report
This report details the work and achievements of the Drug Deaths Taskforce following its establishment in July 2019
Care for Veterans with Substance Use and Mental Health Disorders Requires Improvement
Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report
National Drug Strategy Household Survey 2019
This report presents key results from the 2019 National Drug Strategy Household Survey. It looks at people’s drug use throughout their lives and during the last 12 months, and examines how these patterns have changed over time (AIHW)
Saving Lives in the time of COVID-19
Case Study of Harm Reduction, Homelessness and Drug Use in Dublin, Ireland (LSE)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Addiction Services in Northern Ireland
This report provides an overview of the scale of alcohol and drug addiction in Northern Ireland, the structures and systems in place within the health sector for tackling addiction, and the challenges faced by those accessing addiction services (NIAO)
Philippines: New report reveals deliberate killings of children during “war on drugs”
A new report, published today, documents 122 killings of children, from 1 to 17 years old, throughout the Philippines, between July 2016 and December 2019 (OMCT)
Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia
Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020 (NDARC)
Alcohol and other drug treatment services in Australia, 2018–19
In 2018–19, 1,283 publicly funded alcohol and other drug (AOD) treatment services provided just under 220,000 treatment episodes to an estimated 137,000 clients (AIHW)
Medical use of cannabis
This briefing provides an overview on the recent change in the law and debate on medicinal cannabis products (House of Commons Library UK)
Family Drug and Alcohol Courts under Covid-19: A Practice Briefing
This briefing examines how the nine existing FDACs across England are adapting to service delivery during the current crisis. It highlights the practical challenges facing practitioners, judges and families, and shines a light on specific solutions that have been developed in response to the Covid-19 pandemic (Centre for Justice Innovation)
Safety of low dose cannabidiol
The review identified that there were potential conditions for low dose cannabidiol that would not require oversight by a medical practitioner. (Australian Government)
Novel benzodiazepines: prevalence and harms in the UK
This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government (ACMD)
Gender and Irish Drug Policy
Report submitted to the working group as part of the ‘Implementing a gender approach in different drug policy areas: from prevention, care and treatment service to law enforcement’ project (UCD)
Standard Operating Procedure for using evidence in ACMD reports
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 11
- Next Page »
